CTOs on the Move

Arthur Ashe Institute for Urban Health

www.arthurasheinstitute.com

 
Arthur Ashe Institute for Urban Health is a Brooklyn, NY-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Sunbeam Development Corporation

Sunbeam Development Corporation is a Fishers, IN-based company in the Business Services sector.

Cyderes

Cyderes is a global cybersecurity services provider formed from the merger of Fishtech and Herjavec Group. Established in 2003, the company focuses on cyber defense and response, offering managed security services to help businesses manage and mitigate cyber threats. With over 800 employees, Cyderes operates four Security Operations Centers (SOCs) across the United States, Canada, the United Kingdom, and India, providing round-the-clock monitoring and incident response. The company specializes in identity and access management, professional consulting services, and advanced cyber defense capabilities. Cyderes is recognized for its commitment to enhancing clients cybersecurity posture and has experienced significant growth, including a 340% increase in annual recurring revenue in its first quarter as a merged entity. The leadership of CEO Chris Schueler drives the companys innovative approach in a complex multi-vendor environment.

Hofmann-dietz Architects

Hofmann-dietz Architects is a Gilbert, AZ-based company in the Business Services sector.

Coory Engineering

Coory Engineering is a Santa Fe Springs, CA-based company in the Business Services sector.

Anterios

Anterios is a privately held, clinical-stage biopharmaceutical company that is developing next-generation botulinum-based prescription products for medical dermatology and aesthetic medicine. Anterios has developed NDSTM, a proprietary platform technology that enables local, targeted delivery of botulinum toxin and other macromolecules across the skin without needles or other invasive treatments that can be destructive to the skin. NDS also enables the formulation of macromolecules as ready-to-use liquid injectable products. In the future, Anterios plans to develop additional dermatology products to topically deliver active ingredients other than botulinum, as well as formulate additional injectable products that require deeper delivery.